Evaxion Accounts Payable from 2010 to 2024

EVAX Stock  USD 1.66  0.09  5.73%   
Evaxion Biotech Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 1.9 M in 2024. Accounts Payable is the amount Evaxion Biotech AS owes to suppliers or vendors for products or services received but not yet paid for. It represents Evaxion Biotech's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
2.7 M
Current Value
1.9 M
Quarterly Volatility
1.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Evaxion Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evaxion Biotech's main balance sheet or income statement drivers, such as Interest Income of 1.4 M, Depreciation And Amortization of 330.1 K or Interest Expense of 1 M, as well as many indicators such as Price To Sales Ratio of 206, Dividend Yield of 0.0 or Days Sales Outstanding of 4.3 K. Evaxion financial statements analysis is a perfect complement when working with Evaxion Biotech Valuation or Volatility modules.
  
Check out the analysis of Evaxion Biotech Correlation against competitors.

Latest Evaxion Biotech's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Evaxion Biotech AS over the last few years. An accounting item on the balance sheet that represents Evaxion Biotech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Evaxion Biotech AS are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Evaxion Biotech's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evaxion Biotech's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Evaxion Accounts Payable Regression Statistics

Arithmetic Mean963,970
Geometric Mean257,782
Coefficient Of Variation133.96
Mean Deviation1,117,694
Median59,000
Standard Deviation1,291,308
Sample Variance1.7T
Range3.6M
R-Value0.77
Mean Square Error736.2B
R-Squared0.59
Significance0.0008
Slope221,792
Total Sum of Squares23.3T

Evaxion Accounts Payable History

20241.9 M
20232.7 M
20222.1 M
20212.8 M
20203.7 M
2019646 K
2018139 K

About Evaxion Biotech Financial Statements

Evaxion Biotech investors use historical fundamental indicators, such as Evaxion Biotech's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Evaxion Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable2.7 M1.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Evaxion Stock Analysis

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.